2026. Tralokinumab Significantly Reduces Work Productivity Impairment and Daily Activity Impairment in Adults With Atopic Dermatitis and Moderate-to-Severe Hand Involvement. SKIN The Journal of Cutaneous Medicine. 10, 2 (Mar. 2026), s726. DOI:https://doi.org/10.25251/mjfdzc48.